These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 4622674)
41. [Effectiveness of using lymphocytic interferon on children with acute respiratory viral infections complicated by pneumonia]. Korniienko AB Pediatr Akus Ginekol; 1980; (2):16-7. PubMed ID: 6155658 [No Abstract] [Full Text] [Related]
42. [Interferon - effects and therapeutic possibilities]. Strander H Nord Med; 1981 Mar; 96(3):82-3. PubMed ID: 6164976 [No Abstract] [Full Text] [Related]
43. Interferons for human neoplastic and viral diseases. Borden EC; Hawkins MJ Compr Ther; 1980 Oct; 6(10):6-15. PubMed ID: 6160944 [No Abstract] [Full Text] [Related]
45. A review of approaches to viral chemotherapy. Gordon M; Buchanan RL; Crenshaw RR; Kerridge KA; MacNintch JE; Siminoff P J Med; 1981; 12(5):289-382. PubMed ID: 6171603 [No Abstract] [Full Text] [Related]
46. Inhibitory effect of interferon on the growth of spontaneous mammary tumors in mice. De Clercq E; Zhang ZX; Huygen K; Leyten R J Natl Cancer Inst; 1982 Sep; 69(3):653-7. PubMed ID: 6180210 [TBL] [Abstract][Full Text] [Related]
47. [Clinical use of interferon and its inducers]. Nosik NN; Ershov FI Antibiotiki; 1980 Sep; 25(9):695-710. PubMed ID: 6158289 [No Abstract] [Full Text] [Related]
48. [Interferon. (Obtaining, purification and experimental-clinical study of interferon in the USSR)]. Furer NM; Pokidova NV; Ermol'eva ZV Antibiotiki; 1967 Nov; 12(11):1027-33. PubMed ID: 4875264 [No Abstract] [Full Text] [Related]
49. [The problem of interferon]. Baron S; Cathala F; Levy HE Rev Prat; 1973 Dec; 23(59):5311-4 passim. PubMed ID: 4792653 [No Abstract] [Full Text] [Related]
50. [Chemoprevention and -therapy of virus diseases]. Heidel G Z Gesamte Hyg; 1972 Feb; 18(2):124-30. PubMed ID: 5020574 [No Abstract] [Full Text] [Related]
51. Role of interferon in the protective effect of the double-stranded polyribonucleotide against murine tumors induced by Moloney sarcoma virus. De Clercq E; De Somer P J Natl Cancer Inst; 1971 Dec; 47(6):1345-55. PubMed ID: 5120413 [No Abstract] [Full Text] [Related]
52. [Toxicity of interferon]. Carimantran C Soins; 1988 Aug; (515):15-7. PubMed ID: 2460927 [No Abstract] [Full Text] [Related]
53. Editor's Message - The Faces of Nutrition Research. Royall D Can J Diet Pract Res; 1998; 59(4):171. PubMed ID: 11551355 [No Abstract] [Full Text] [Related]
55. Editor's Corner: a look at current hypertension research from this issue content. Zanchetti A J Hypertens; 2013 Feb; 31(2):221-2. PubMed ID: 23303346 [No Abstract] [Full Text] [Related]
57. The copy editor's lament on who put the period in Charles C Thomas. LEWIS AR Miss Valley Med J; 1959 Jan; 81(1):41-3. PubMed ID: 13632627 [No Abstract] [Full Text] [Related]
58. Editor's interview: interferon. Young CW CA Cancer J Clin; 1972; 22(1):27-9. PubMed ID: 4622674 [No Abstract] [Full Text] [Related]
59. The use of interferon in viral hepatitis B. Desmyter J Tex Rep Biol Med; 1977; 35():516-22. PubMed ID: 358473 [No Abstract] [Full Text] [Related]
60. Interferons: therapeutic prospects. Finter NB Mod Trends Med Virol; 1970; 2(0):262-83. PubMed ID: 4950660 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]